Understand the Competitive Environment within the Cough, Cold and Allergy Remedies Market in Japan

Business Wire, Feb 6, 2006

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c32181) has announced the addition of Cough, Cold and Allergy (Hay Fever) Remedies in Japan to their offering.

The Cough, Cold and Allergy Products in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage: decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

--Get a detailed picture of the cough, cold and allergy (hayfever) industry

--Identify factors driving change

--Understand the competitive environment, the market's major players and leading brands

--Use five-year forecasts to assess how the market is predicted to develop

Companies Mentioned Include:

--Taisho Pharmaceutical Co Ltd

--Otsuka Pharmaceutical Co Ltd

--Takeda Chemical Industries Ltd

--Sato Pharmaceutical Co Ltd

--SSP Co Ltd

--Miki Corp

--Kowa Co Ltd

--Amway Japan Ltd

--Sankyo Co Ltd

--Rohto Pharmaceutical Co Ltd

--Lion Corp

--Asahi Food & Healthcare Co Ltd

--Fancl Corp

--Kobayashi Pharmaceutical Co Ltd

--Eisai Co Ltd

--Zepharma Inc

--Taiho Pharmaceutical Co Ltd

--Zeria Pharmaceutical Co Ltd

--Yomeishu Seizo Co Ltd

--Hisamitsu Pharmaceutical Co Inc

--Bristol-Myers Lion Ltd

--Meiji Seika Kaisha Ltd

--Zenyaku Kogyo Co Ltd

--Nu Skin Japan Co Ltd

--Daiichi Pharmaceutical Co Ltd

--Tokiwa Chemical Industries Ltd

--Taiko Pharmaceutical Co Ltd

--Shionogi & Co Ltd

--Lotte Co Ltd

--GlaxoSmithKline KK

--Coca-Cola (Japan) Co Ltd

--Sun Chlorella Corp

--Kanro Co Ltd

--Pfizer Consumer Inc

--Suntory Ltd

--Shaklee Japan KK

--Oda Pharmaceutical Co Ltd

--Santen Pharmaceutical Co Ltd

--Tanabe Seiyaku Co Ltd

--Herbalife International of Japan KK

--Wakamoto Pharmaceutical Co Ltd

--DHC Corp

--Arax Pharmaceutical Co Ltd

--Asadaame Co Ltd

--Cadbury Japan Ltd

--Kirin Well-Foods Co Ltd

--Johnson & Johnson KK

--Shiseido Pharmaceutical Co Ltd

--Tokuhon Corp

--Nichiban Co Ltd

--Morishita Jintan Co Ltd

--Yakult Honsha Co Ltd

--Omi Brotherhood Co Ltd

--Ichijiku Pharmaceutical Co Ltd

--Kyushin Pharmaceutical Co Ltd

--Ikeda Mohando Co Ltd

--House Foods Corp

--Kawai Pharmaceutical Co Ltd

--Pfizer Japan Inc

--Ryukakusan Co Ltd

--Shiseido Co Ltd

--Wada Calcium Pharmaceutical Co Ltd

--Bristol-Myers (Japan) Ltd

--Nivea-Kao Co Ltd

--Dai Nippon Pharmaceutical Co Ltd

--Pigeon Corp

--Hoyu Co Ltd

--Bayer Yakuhin Ltd

--Pfizer Japan Inc

--Chugai Pharmaceutical Co Ltd

--Fujisawa Pharmaceutical Co Ltd

--Yamanouchi Pharmaceutical Co Ltd

--Warner-Lambert Inc

--Procter & Gamble Far East Inc

For more information visit http://www.researchandmarkets.com/reports/c32181